Keywords: exelixis, plans, start, clinical, trials, xl647, usa-based

Exelixis plans to start clinical trials of XL647

Article | 01 March 2004

Print This

USA-based Exelixis has submitted an Investigational New Drug application with the US Food and Drug Administration for XL647, a potential ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in